{
    "clinical_study": {
        "@rank": "3167", 
        "arm_group": [
            {
                "arm_group_label": "Total intravenous anesthesia", 
                "arm_group_type": "Active Comparator", 
                "description": "Total intravenous anaesthesia"
            }, 
            {
                "arm_group_label": "Balanced anesthesia", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aimed to evaluate the possible protective effect of anesthetic technique\n      balanced(with sevoflurane) compared with total intravenous anesthetic technique\n      (propofol,remifentanil). The hypothesis is that the Sevoflurane may exert protective effect\n      in regard to the ischemia-reperfusion injury induced on the microsurgical breast free flap\n      during transfer to receiving area. The investigators will evaluate the continuous flap\n      tissue oximetry and the level of biochemical markers."
        }, 
        "brief_title": "Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Microsurgical Free Flaps", 
        "condition_browse": {
            "mesh_term": [
                "Ischemia", 
                "Reperfusion Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patient selected for plastic breast surgery With microsurgical Free flap Over 18 y Asa\n        I/II\n\n        Exclusion Criteria:\n\n        Unusual reaction to anesthetic drugs Suspect for malignant hyperthermia Vasculopathic\n        disease Coagulation disease"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "132", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01905501", 
            "org_study_id": "Versione 02.01.2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Balanced anesthesia", 
                "description": "Et-Sevo maIntained 1,8-2%, remifentanyl according  target-controlled infusion maintained 1-3 ng/ml", 
                "intervention_name": "Balanced anesthesia", 
                "intervention_type": "Drug", 
                "other_name": "Inhalation anesthesia"
            }, 
            {
                "arm_group_label": "Total intravenous anesthesia", 
                "description": "Propofol  3-4 \u00b5g/ml and remifentanyl 1-3 ng/ml according target-controlled infusion", 
                "intervention_name": "Total intravenous anesthesia", 
                "intervention_type": "Drug", 
                "other_name": "TIVA-TCI"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Sevoflurane"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Balanced anesthesia", 
            "Inhalation anesthesia", 
            "Reperfusion injury", 
            "Microsurgical Free flap"
        ], 
        "lastchanged_date": "July 22, 2013", 
        "location": {
            "contact": {
                "email": "forastiere@ifo.it", 
                "last_name": "Ester Forastiere, M.D."
            }, 
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00144"
                }, 
                "name": "Regina Elena CI"
            }, 
            "investigator": {
                "last_name": "Ester Forastiere, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Sevoflurane Protective Effect on Ischemia-reperfusion Injury in Patients Undergoing Reconstructive Plastic Surgery  With  Microsurgical Flap. Multicenter, Randomized Controlled Trial.", 
        "overall_contact": {
            "email": "forastiere@ifo.it", 
            "last_name": "Ester Forastiere"
        }, 
        "overall_official": {
            "affiliation": "Regina Elena CI", 
            "last_name": "Ester Forastiere, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "continuous tissue oximetry (NIRS)", 
            "safety_issue": "Yes", 
            "time_frame": "20 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01905501"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Regina Elena Cancer Institute", 
            "investigator_full_name": "Ester Forastiere", 
            "investigator_title": "M.D., Chief of Critical Area Department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Biochemical Markers", 
                "safety_issue": "Yes", 
                "time_frame": "Preoperative and 24 hours post operative"
            }, 
            {
                "measure": "Lactate Clearance", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Regina Elena Cancer Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Regina Elena Cancer Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}